Zobrazeno 1 - 10
of 481
pro vyhledávání: '"Patrick A Kupelian"'
Autor:
Daniel Grossi Marconi, Bruno da Costa Resende, Erick Rauber, Paula de Cassia Soares, Jose Maria Fernandes, Niraj Mehta, Andre Lopes Carvalho, Patrick A Kupelian, Allen Chen
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0156544 (2016)
To report a single-institutional experience with the use of Superficial X-Ray Therapy (SXRT) for head and neck non-melanoma skin cancer (N-MSC) and to compare outcomes by prescribed fractionation schedules.The medical records of 597 patients with 102
Externí odkaz:
https://doaj.org/article/cd480b7ac18a439590ecb8643be74c8f
Autor:
Luca F. Valle, Dan Ruan, Audrey Dang, Rebecca G. Levin-Epstein, Ankur P. Patel, Joanne B. Weidhaas, Nicholas G. Nickols, Percy P. Lee, Daniel A. Low, X. Sharon Qi, Christopher R. King, Michael L. Steinberg, Patrick A. Kupelian, Minsong Cao, Amar U. Kishan
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Purpose: Dosimetric predictors of toxicity after Stereotactic Body Radiation Therapy (SBRT) are not well-established. We sought to develop a multivariate model that predicts Common Terminology Criteria for Adverse Events (CTCAE) late grade 2 or great
Externí odkaz:
https://doaj.org/article/60874e575f344154b3e7c2f6a065d3ec
Autor:
Michael L. Steinberg, Kathleen Nguyen, Vinayak Muralidhar, Neil R. Parikh, Vincent Lok, Ting Martin Ma, Ida Sonni, Andrei Gafita, Pan Thin, David Elashoff, Johannes Czernin, Ricky Savjani, Matthew Rettig, Jesus E. Juarez, Jie Deng, Tristan Grogan, David Shabsovich, Amar U. Kishan, Patrick A. Kupelian, David D. Yang, Jeremie Calais, Nicholas G. Nickols, Carissa Chu, Felix Y. Feng, Wesley R Armstrong, Robert E. Reiter
Publikováno v:
Eur Urol Oncol
European urology oncology, vol 5, iss 1
European urology oncology, vol 5, iss 1
Prostate-specific membrane antigen (PSMA) positron emission tomography (PET)/computed tomography (CT) is an emerging imaging modality with greater sensitivity and specificity over conventional imaging for prostate cancer (PCa) staging. Using data fro
Autor:
Amar U. Kishan, Albert J. Chang, Daniel E. Spratt, Christopher R. King, Michael L. Steinberg, Ann C. Raldow, Fang-I Chu, Matthew Rettig, Karim Chamie, Paul L. Nguyen, Chenyang Wang, Robert T. Dess, Sandy T. Liu, Patrick A. Kupelian, Christopher S. Saigal, Nicholas G. Nickols, Mark S. Litwin, James B. Yu, Robert E. Reiter
Publikováno v:
European Urology Oncology. 4:327-330
Multiple randomized trials have shown a survival benefit to long durations of androgen deprivation therapy (ADT) in patients with Gleason grade group (GG) 4-5 (ie, Gleason score 8-10) prostate cancer (PCa) undergoing definitive external beam radiothe
Autor:
Rebecca Levin-Epstein, Naomi Y. Jiang, Jay Patel, Sartajdeep Kahlon, Nicholas D. Prionas, Nicholas G. Zaorsky, Shrinivasa K. Upadhyaya, Leszek Miszczyk, Sean P. Collins, Nicholas G. Nickols, Minsong Cao, Felix Y. Feng, Osama Mohamad, Nima Aghdam, Ye Yuan, Donald B. Fuller, Nzhde Agazaryan, A.T. Dang, Paul C. Boutros, A.U. Kishan, Constantine Mantz, Brandon A. Mahal, Amar U. Kishan, Daniel E. Spratt, Mark K. Buyyounouski, Michael L. Steinberg, David Shabsovich, Patrick A. Kupelian, Simeng Suy, Hilary P. Bagshaw, Alan J. Katz, Xiaoyan Wang, Tommy Jiang, Jesus E. Juarez, A. Napieralska, Ankur D. Patel, Agnieszka Namysł-Kaletka
Publikováno v:
Radiother Oncol
Background and purposeThe optimal dose for prostate stereotactic body radiotherapy (SBRT) is still unknown. This study evaluated the dose-response relationships for prostate-specific antigen (PSA) decay and biochemical recurrence (BCR) among 4 SBRT d
Autor:
Amar U. Kishan, Alison Steigler, James W. Denham, Almudena Zapatero, Araceli Guerrero, David Joseph, Xavier Maldonado, Jessica K. Wong, Bradley J. Stish, Robert T. Dess, Avinash Pilar, Chandana Reddy, Trude B. Wedde, Wolfgang A. Lilleby, Ryan Fiano, Gregory S. Merrick, Richard G. Stock, D. Jeffrey Demanes, Brian J. Moran, Phuoc T. Tran, Santiago Martin, Rafael Martinez-Monge, Daniel J. Krauss, Eyad I. Abu-Isa, Thomas M. Pisansky, C. Richard Choo, Daniel Y. Song, Stephen Greco, Curtiland Deville, Todd McNutt, Theodore L. DeWeese, Ashley E. Ross, Jay P. Ciezki, Derya Tilki, R. Jeffrey Karnes, Jeffrey J. Tosoian, Nicholas G. Nickols, Prashant Bhat, David Shabsovich, Jesus E. Juarez, Tommy Jiang, T. Martin Ma, Michael Xiang, Rebecca Philipson, Albert Chang, Patrick A. Kupelian, Matthew B. Rettig, Felix Y. Feng, Alejandro Berlin, Jonathan D. Tward, Brian J. Davis, Robert E. Reiter, Michael L. Steinberg, David Elashoff, Paul C. Boutros, Eric M. Horwitz, Rahul D. Tendulkar, Daniel E. Spratt, Tahmineh Romero
Publikováno v:
JAMA oncology, vol 8, iss 3
JAMA Oncology
JAMA Oncology
Key Points Question What is the optimal minimum duration of androgen deprivation therapy (ADT) when treating high-risk prostate cancer with high-dose radiotherapy? Findings This patient-level cohort study of 3 cohorts found a significant interaction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf4397cad9de2f66c9946476bffe693
https://escholarship.org/uc/item/9m28n0vg
https://escholarship.org/uc/item/9m28n0vg
Autor:
Fabio de Lima Costa Faustino, Wanessa Fernanda Altei, Heloisa Pelisser Canton, Leonardo Morato, Livia Loami Ruys Jorge de Paula, Gabriela Bernal Salvador, Diego de Souza Lima Fonseca, Thais Kapp Gonçalves, Patrick A. Kupelian, Jose Carlos Zaparolli, Laura Ercolin, Daniel Grossi Marconi
Publikováno v:
Practical radiation oncology. 12(4)
This study evaluated the toxicity associated with a short course dose-escalated hypofractionated radiation therapy (HFRT) using image guided RT with or without androgen suppression therapy in patients with prostate cancer.This single-center prospecti
Autor:
Michael L. Steinberg, Christopher R. King, Ekambaram Ganapathy, Matthew Rettig, Beatrice S. Knudsen, Minsong Cao, Christine Nguyen, Ramin Nazarian, Fang-I Chu, David Elashoff, Vince Basehart, Tahmineh Romero, Care Felix, Silvia Diaz-Perez, Nicholas G. Nickols, Dörthe Schaue, Nazy Zomorodian, Jae Kwak, Nathanael Kane, Lin Lin, Robert E. Reiter, Colleen Mathis, Patrick A. Kupelian, Amar U. Kishan
Publikováno v:
Prostate cancer and prostatic diseases
Prostate cancer and prostatic diseases, vol 24, iss 1
Prostate cancer and prostatic diseases, vol 24, iss 1
BackgroundHundreds of ongoing clinical trials combine radiation therapy, mostly delivered as stereotactic body radiotherapy (SBRT), with immune checkpoint blockade. However, our understanding of the effect of radiotherapy on the intratumoral immune b
Autor:
Fang-I Chu, Amar U. Kishan, Ye Yuan, Christopher R. King, A. Napieralska, Nicolas D. Prionas, Constantine Mantz, Leszek Miszczyk, Nima Aghdam, Daniel E. Spratt, Hilary P. Bagshaw, Naomi Y. Jiang, Nicholas G. Nickols, Agnieszka Namysł-Kaletka, David Shabsovich, Michael L. Steinberg, Mark K. Buyyounouski, William C. Jackson, Patrick A. Kupelian, Simeng Suy, Sean P. Collins, Audrey Dang
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:628-636
Purpose Understanding prostate-specific antigen (PSA) kinetics after radiation therapy plays a large role in the management of patients with prostate cancer (PCa). This is particularly true in establishing expectations regarding PSA nadir (nPSA) and
Autor:
Eyad Abu-Isa, Albert J. Chang, Wolfgang Lilleby, Jeffrey J. Tosoian, Robert E. Reiter, Brian J. Moran, Robert T. Dess, Trude B. Wedde, Theodore L. DeWeese, D. Jeffrey Demanes, Patrick A. Kupelian, Todd McNutt, Ridwan Alam, Prashant Bhat, Tahmineh Romero, Santiago Martin, Daniel E. Spratt, Thomas M. Pisansky, Nicholas G. Nickols, Giovanni Motterle, Rafael Martínez-Monge, J.K. Wong, Gregory S. Merrick, Derya Tilki, Matthew Rettig, R. Jeffrey Karnes, Jesus E. Juarez, Michael L. Steinberg, Phuoc T. Tran, Hartwig Huland, Bradley J. Stish, Eric M. Horwitz, David Elashoff, Danny Y. Song, Bruce J. Trock, Alejandro Berlin, Chandana A. Reddy, David Shabsovich, Daniel J. Krauss, Brian J. Davis, Eric A. Klein, Michelle H. Braccioforte, Curtiland Deville, Rahul D. Tendulkar, Richard G. Stock, Natalie Chong, Paul C. Boutros, Jay P. Ciezki, Jonathan D. Tward, Ryan Fiano, Rebecca Levin-Epstein, Zeyad Schwen, Richard Choo, Ashley E. Ross, Avinash Pilar, Anthony V. D'Amico, Amar U. Kishan, Stephen Greco
Publikováno v:
JAMA Network Open
Key Points Question Are external beam radiotherapy, with or without brachytherapy boost, or radical prostatectomy associated with differences in prostate cancer–specific mortality or distant metastasis outcomes in patients with high-risk prostate c